Forsta AP Fonden Grows Stock Position in Molina Healthcare, Inc. (NYSE:MOH)

Forsta AP Fonden increased its holdings in Molina Healthcare, Inc. (NYSE:MOH) by 3.4% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 12,300 shares of the company’s stock after acquiring an additional 400 shares during the period. Forsta AP Fonden’s holdings in Molina Healthcare were worth $3,580,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Marshall Wace LLP purchased a new stake in Molina Healthcare in the second quarter valued at approximately $416,000. Algert Global LLC purchased a new stake in shares of Molina Healthcare in the 2nd quarter valued at $211,000. Sanctuary Advisors LLC acquired a new position in Molina Healthcare during the 2nd quarter worth about $1,077,000. Czech National Bank boosted its holdings in Molina Healthcare by 6.9% during the 3rd quarter. Czech National Bank now owns 11,937 shares of the company’s stock valued at $4,113,000 after acquiring an additional 771 shares during the period. Finally, Handelsbanken Fonder AB grew its position in Molina Healthcare by 23.0% in the 3rd quarter. Handelsbanken Fonder AB now owns 14,437 shares of the company’s stock valued at $4,974,000 after acquiring an additional 2,700 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Stock Down 0.9 %

MOH stock opened at $310.10 on Friday. The stock has a market cap of $17.74 billion, a P/E ratio of 15.75, a PEG ratio of 0.94 and a beta of 0.54. The company has a current ratio of 1.54, a quick ratio of 1.55 and a debt-to-equity ratio of 0.53. Molina Healthcare, Inc. has a twelve month low of $272.69 and a twelve month high of $423.92. The company’s 50 day moving average is $297.44 and its two-hundred day moving average is $317.79.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Robert W. Baird reduced their price target on shares of Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Wells Fargo & Company boosted their price target on shares of Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a research note on Monday, November 4th. StockNews.com upgraded Molina Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Friday. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $350.00 target price (down from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Finally, Barclays upped their price target on Molina Healthcare from $359.00 to $372.00 and gave the stock an “equal weight” rating in a report on Friday, October 25th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Molina Healthcare has an average rating of “Moderate Buy” and a consensus target price of $359.18.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.